GLYCOFI TO PRESENT KEYNOTE LECTURE AT UPCOMING SOCIETY FOR INDUSTRIAL MICROBIOLOGY CONFERENCE

Lebanon, NH ( November 2, 2005) –GlycoFi’s Chief Scientific Officer, Tillman Gerngross, Ph.D. will present the keynote lecture at the upcoming Recent Advances in Fermentation Technology conference. The conference is jointly sponsored by the Society for Industrial Microbiology and the American Chemical Society and will be held at the Hyatt Regency in Long Beach, CA November 6 – 9, 2005. Dr. Gerngross’ lecture is entitled “ Production of complex human glycoproteins in yeast and fungi” and will be presented at 11 am on Sunday November 6.
 
About GlycoFi

GlycoFi is a private, venture-backed, biotechnology company whose investors include Polaris Venture Partners, SV Life Sciences, Boston Millennia Partners, Fletcher Spaght Ventures, Eli Lilly & Company, and International Biotechnology Trust. GlycoFi leverages its pioneering protein optimization technology to develop, produce and commercialize Next Generation Biotherapeutics™, alone and in partnership with other leading biopharmaceutical companies. For additional information please visit www.glycofi.com.

GlycoFi Contacts:

James Posada, Ph.D., MBA
Senior Vice President
Business & Market Development, GlycoFi
jposada@glycofi.com
(603) 727-5181

Joan Kureczka
Kureczka/Martin Associates
jkureczka@comcast.net
(415) 821-2413